4 ms·
Novel Oral Polio Vaccine type 2 (nOPV2) granted EUL recommendation
- divbzero 6y agonOPV2 is significant in that it should decrease the risk of vaccine-derived polioviruses — one of the lingering challenges as we get closer and closer to fully eradicating the disease.